Cognitive Behavioral Therapy and Chronic Pain Self-Management Within the Context of Opioid Reduction
| Status: | Recruiting |
|---|---|
| Conditions: | Chronic Pain, Chronic Pain |
| Therapuetic Areas: | Musculoskeletal |
| Healthy: | No |
| Age Range: | 18 - 85 |
| Updated: | 8/5/2018 |
| Start Date: | July 24, 2018 |
| End Date: | November 1, 2022 |
| Contact: | Eric A Dixon, B.A. |
| Email: | eadixon@stanford.edu |
| Phone: | (650) 725-1646 |
Comparative Effectiveness of Pain Cognitive Behavioral Therapy and Chronic Pain Self-Management Within the Context of Opioid Reduction
The proposed study will fill several critical gaps in evidence that are preventing patients
and physicians from making informed decisions about their pain care. This project will
provide patients taking opioids and physicians with the specific evidence they need to choose
the most effective route to pain control, reduced pain interference, opioid reduction, and
improved role function, thereby improving patient care.
The aims of this study are to (1) reduce or contain prescription opioid use while maintaining
pain control and (2) compare the effectiveness of the Chronic Pain Self-Management Program
(CPSMP), Cognitive Behavioral Therapy for chronic pain (pain-CBT), and no behavioral
treatment within the context of patient-centered collaborative opioid tapering (Taper Only).
and physicians from making informed decisions about their pain care. This project will
provide patients taking opioids and physicians with the specific evidence they need to choose
the most effective route to pain control, reduced pain interference, opioid reduction, and
improved role function, thereby improving patient care.
The aims of this study are to (1) reduce or contain prescription opioid use while maintaining
pain control and (2) compare the effectiveness of the Chronic Pain Self-Management Program
(CPSMP), Cognitive Behavioral Therapy for chronic pain (pain-CBT), and no behavioral
treatment within the context of patient-centered collaborative opioid tapering (Taper Only).
Inclusion Criteria:
- Chronic non-cancer pain (≥ 6 months in duration)
- Currently receiving prescription opioids (≥ 10 MEDD) for ≥ 3 months
Exclusion Criteria:
- Unable to provide informed consent
- Unable to participate in group treatments in a meaningful way (e.g., evident cognitive
impairment or lack of English fluency)
- Moderate to severe opioid use disorder
We found this trial at
1
site
Click here to add this to my saved trials
